search
Back to results

Early Left Atrial Septostomy Versus Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation (EARLY-UNLOAD)

Primary Purpose

Cardiogenic Shock

Status
Active
Phase
Not Applicable
Locations
Korea, Republic of
Study Type
Interventional
Intervention
Early left atrial septostomy within 12 hours after VA-ECMO implantation
Selective left atrial septostomy
Sponsored by
Chonnam National University Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Cardiogenic Shock focused on measuring Extracorporeal membrane oxygenation, Myocardial Infarction, Heart Diseases, Cardiovascular Diseases, Coronary Disease

Eligibility Criteria

19 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

1) Age more than 18 years old 2) Cardiogenic shock* 3) Successful VA-ECMO implantation

  • The definition of cardiogenic shock All these criteria should be met

    1. Systolic blood pressure < 90 mmHg for 30 minutes, or needing inotrope or vasopressor to maintain systolic blood pressure > or = 90 mmHg
    2. Pulmonary congestion on chest X-ray or increased left ventricular filling pressure by cardiac catheterization
    3. At least one criteria of organ dysfunction

      - mental obtundation, clammy skin, oliguria, renal dysfunction, increased level of blood lactate

      Exclusion Criteria:

    1. VA-ECMO after open heart surgery
    2. VA-ECMO for the treatment of non-cardiac shock
    3. Severe bleeding*
    4. Terminal malignancy
    5. Irreversible brain damage
    6. Pregnancy or lactation
  • The definition of severe bleeding Hemoglobin decrease after VA-ECMO or cannulation site bleeding is not a exclusion criteria

    1. Hypovolemic shock due to definite bleeding cause
    2. Identifiable bleeding causes: gastrointestinal bleeding, hemothorax, traumatic bleeding, central nervous system hemorrhage, pulmonary hemorrhage

Sites / Locations

  • Chonnam National University Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Early left atrial septostomy group

Conventional approach group

Arm Description

Early left atrial septostomy group will routinely receive left atrial septostomy within 12 hours after VA-ECMO implantation.

Conventional approach group will receive left atrial septostomy in cases of deleterious effect of increased LVEDP after VA-ECMO implantation, such as refractory pulmonary edema, abnormal opening of aortic valve, left ventricular dilatation, refractory ventricular tachycardia or fibrillation.

Outcomes

Primary Outcome Measures

Cumulative incidence rate of all-cause death
Cumulative incidence rate of all-cause death

Secondary Outcome Measures

Rate of all-cause death or left atrial septostomy in conventional approach group
Rate of all-cause death or left atrial septostomy in conventional approach group
Rate of left atrial septostomy in conventional approach group
Rate of left atrial septostomy in conventional approach group
Incidence rate of all-cause death during index admission
Incidence rate of all-cause death during index admission
Cumulative incidence rate of cardiac death
Cumulative incidence rate of cardiac death
Cumulative incidence rate of non-cardiac death
Cumulative incidence rate of non-cardiac death
Weaning rate from venoarterial extracorporeal membrane oxygenation during index admission
Weaning rate from venoarterial extracorporeal membrane oxygenation during index admission
Rate of disappearance of pulmonary edema on chest X-ray during index admission
Rate of disappearance of pulmonary edema on chest X-ray during index admission
Weaning rate from mechanical ventilator during index admission
Weaning rate from mechanical ventilator during index admission
Intensive care unit length of stay during index admission
Intensive care unit length of stay during index admission
Hospital length of stay
Hospital length of stay
Lactate normalization rate
Lactate normalization rate
Lactate clearance rate
Lactate clearance rate
Rate of renal replacement therapy during index admission
Rate of renal replacement therapy during index admission
Rate of limb ischemia during index admission
Rate of limb ischemia during index admission
Rate of infection during index admission
Rate of infection during index admission
Rate of transient ischemic attack or stroke during index admission
Rate of transient ischemic attack or stroke during index admission
Rate of BARC bleeding type 3 or 5 during index admission
Rate of BARC bleeding type 3 or 5 during index admission
Rate of bridge to ventricular assist device or heart transplantation during index admission
Rate of bridge to ventricular assist device or heart transplantation during index admission
Rate of major vascular injury or cardiac tamponade during left atrial septostomy
Rate of major vascular injury or cardiac tamponade during left atrial septostomy
Cumulative incidence rate of all-cause death
Cumulative incidence rate of all-cause death
Cumulative incidence rate of cardiac death
Cumulative incidence rate of cardiac death
Cumulative incidence rate of non-cardiac death
Cumulative incidence rate of non-cardiac death
Re-hospitalization rate due to heart failure
Re-hospitalization rate due to heart failure
All-cause death or re-hospitalization rate due to heart failure
All-cause death or re-hospitalization rate due to heart failure

Full Information

First Posted
February 24, 2021
Last Updated
December 21, 2022
Sponsor
Chonnam National University Hospital
search

1. Study Identification

Unique Protocol Identification Number
NCT04775472
Brief Title
Early Left Atrial Septostomy Versus Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation
Acronym
EARLY-UNLOAD
Official Title
Early Left Atrial Septostomy Versus Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation: A Randomized Controlled Study
Study Type
Interventional

2. Study Status

Record Verification Date
December 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
March 4, 2021 (Actual)
Primary Completion Date
October 15, 2022 (Actual)
Study Completion Date
October 31, 2023 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Chonnam National University Hospital

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The use of venoarterial-extracorporeal membrane oxygenation(VA-ECMO) was associated with lower in-hospital mortality in patients with cardiogenic shock. However, VA-ECMO has a deleterious effect for hemodynamics. It can increase left ventricular end-diastolic pressure(LVEDP), followed by left ventricular dilatation, abnormal opening of aortic valve and jeopardizes of myocardial recovery. Therefore, several methods have been used to reduce LVEDP. Among these, left atrial septostomy is effective, but less invasive than surgical left ventricular unloading. However, there is few data regarding this issue. Therefore, the investigators will evaluate the effect of routine, early left atrial septostomy in patients with VA-ECMO for the treatment of cardiogenic shock.
Detailed Description
Study Objectives: To determine the effect of early left atrial septostomy versus conventional approach(left atrial septostomy only in cases of significant changes due to left ventricular end-diastolic pressure increase) in patients who received venoarterial-extracorporeal membrane oxygenation(VA-ECMO) for the treatment of cardiogenic shock. Study Background: Cardiogenic shock is due to myocardial dysfunction from multifactorial causes, which has high mortality. The treatment for cardiogenic shock includes early coronary revascularization, inotropes, vasopressors, or mechanical circulatory support, such as intraaortic balloon pump(IABP), VA-ECMO. However, the routine use of IABP is not recommended for the treatment of cardiogenic shock in recent guidelines. VA-ECMO can be easily implanted, and can maintain high cardiac output. In several studies, The use of VA-ECMO was associated with lower in-hospital mortality in patients with cardiogenic shock. However, VA-ECMO has a deleterious effect for hemodynamics. It can increase left ventricular end-diastolic pressure(LVEDP), followed by left ventricular dilatation, abnormal opening of aortic valve and jeopardizes of myocardial recovery. Therefore, several methods have been used to reduce LVEDP. Among these, left atrial septostomy is effective, but less invasive than surgical left ventricular unloading. However, there is few data regarding this issue. Therefore, the investigators will evaluate the effect of routine, early left atrial septostomy in patients with VA-ECMO for the treatment of cardiogenic shock. Study Hypothesis: Early, routine left atrial septostomy for left heart unloading is superior compared to conventional approach to reduce in-hospital mortality and the duration of VA-ECMO.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cardiogenic Shock
Keywords
Extracorporeal membrane oxygenation, Myocardial Infarction, Heart Diseases, Cardiovascular Diseases, Coronary Disease

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
116 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Early left atrial septostomy group
Arm Type
Experimental
Arm Description
Early left atrial septostomy group will routinely receive left atrial septostomy within 12 hours after VA-ECMO implantation.
Arm Title
Conventional approach group
Arm Type
Active Comparator
Arm Description
Conventional approach group will receive left atrial septostomy in cases of deleterious effect of increased LVEDP after VA-ECMO implantation, such as refractory pulmonary edema, abnormal opening of aortic valve, left ventricular dilatation, refractory ventricular tachycardia or fibrillation.
Intervention Type
Procedure
Intervention Name(s)
Early left atrial septostomy within 12 hours after VA-ECMO implantation
Intervention Description
Early left atrial septostomy group will routinely receive left atrial septostomy within 12 hours after VA-ECMO implantation. Left atrial septostomy will be done using percutaneous technique.
Intervention Type
Procedure
Intervention Name(s)
Selective left atrial septostomy
Intervention Description
Left atrial septostomy will be done in cases of deleterious effect of increased LVEDP after VA-ECMO implantation, such as refractory pulmonary edema, abnormal opening of aortic valve, left ventricular dilatation, refractory ventricular tachycardia or fibrillation.
Primary Outcome Measure Information:
Title
Cumulative incidence rate of all-cause death
Description
Cumulative incidence rate of all-cause death
Time Frame
Up to 30 days
Secondary Outcome Measure Information:
Title
Rate of all-cause death or left atrial septostomy in conventional approach group
Description
Rate of all-cause death or left atrial septostomy in conventional approach group
Time Frame
Up to 30 days
Title
Rate of left atrial septostomy in conventional approach group
Description
Rate of left atrial septostomy in conventional approach group
Time Frame
Up to 30 days
Title
Incidence rate of all-cause death during index admission
Description
Incidence rate of all-cause death during index admission
Time Frame
Up to 6 months
Title
Cumulative incidence rate of cardiac death
Description
Cumulative incidence rate of cardiac death
Time Frame
Up to 30 days
Title
Cumulative incidence rate of non-cardiac death
Description
Cumulative incidence rate of non-cardiac death
Time Frame
Up to 30 days
Title
Weaning rate from venoarterial extracorporeal membrane oxygenation during index admission
Description
Weaning rate from venoarterial extracorporeal membrane oxygenation during index admission
Time Frame
Up to 6 months
Title
Rate of disappearance of pulmonary edema on chest X-ray during index admission
Description
Rate of disappearance of pulmonary edema on chest X-ray during index admission
Time Frame
Up to 6 months
Title
Weaning rate from mechanical ventilator during index admission
Description
Weaning rate from mechanical ventilator during index admission
Time Frame
Up to 6 months
Title
Intensive care unit length of stay during index admission
Description
Intensive care unit length of stay during index admission
Time Frame
Up to 6 months
Title
Hospital length of stay
Description
Hospital length of stay
Time Frame
Up to 6 months
Title
Lactate normalization rate
Description
Lactate normalization rate
Time Frame
Up to 30 days
Title
Lactate clearance rate
Description
Lactate clearance rate
Time Frame
Up to 30 days
Title
Rate of renal replacement therapy during index admission
Description
Rate of renal replacement therapy during index admission
Time Frame
Up to 6 months
Title
Rate of limb ischemia during index admission
Description
Rate of limb ischemia during index admission
Time Frame
Up to 6 months
Title
Rate of infection during index admission
Description
Rate of infection during index admission
Time Frame
Up to 6 months
Title
Rate of transient ischemic attack or stroke during index admission
Description
Rate of transient ischemic attack or stroke during index admission
Time Frame
Up to 6 months
Title
Rate of BARC bleeding type 3 or 5 during index admission
Description
Rate of BARC bleeding type 3 or 5 during index admission
Time Frame
Up to 6 months
Title
Rate of bridge to ventricular assist device or heart transplantation during index admission
Description
Rate of bridge to ventricular assist device or heart transplantation during index admission
Time Frame
Up to 6 months
Title
Rate of major vascular injury or cardiac tamponade during left atrial septostomy
Description
Rate of major vascular injury or cardiac tamponade during left atrial septostomy
Time Frame
Up to 30 days
Title
Cumulative incidence rate of all-cause death
Description
Cumulative incidence rate of all-cause death
Time Frame
Up to 12 months
Title
Cumulative incidence rate of cardiac death
Description
Cumulative incidence rate of cardiac death
Time Frame
Up to 12 months
Title
Cumulative incidence rate of non-cardiac death
Description
Cumulative incidence rate of non-cardiac death
Time Frame
Up to 12 months
Title
Re-hospitalization rate due to heart failure
Description
Re-hospitalization rate due to heart failure
Time Frame
Up to 12 months
Title
All-cause death or re-hospitalization rate due to heart failure
Description
All-cause death or re-hospitalization rate due to heart failure
Time Frame
Up to 12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
19 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 1) Age more than 18 years old 2) Cardiogenic shock* 3) Successful VA-ECMO implantation The definition of cardiogenic shock All these criteria should be met Systolic blood pressure < 90 mmHg for 30 minutes, or needing inotrope or vasopressor to maintain systolic blood pressure > or = 90 mmHg Pulmonary congestion on chest X-ray or increased left ventricular filling pressure by cardiac catheterization At least one criteria of organ dysfunction - mental obtundation, clammy skin, oliguria, renal dysfunction, increased level of blood lactate Exclusion Criteria: VA-ECMO after open heart surgery VA-ECMO for the treatment of non-cardiac shock Severe bleeding* Terminal malignancy Irreversible brain damage Pregnancy or lactation The definition of severe bleeding Hemoglobin decrease after VA-ECMO or cannulation site bleeding is not a exclusion criteria Hypovolemic shock due to definite bleeding cause Identifiable bleeding causes: gastrointestinal bleeding, hemothorax, traumatic bleeding, central nervous system hemorrhage, pulmonary hemorrhage
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Min Chul Kim, Professor
Organizational Affiliation
Chonnam National University Hospital
Official's Role
Principal Investigator
Facility Information:
Facility Name
Chonnam National University Hospital
City
Gwangju
Country
Korea, Republic of

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Early Left Atrial Septostomy Versus Conventional Approach After Venoarterial Extracorporeal Membrane Oxygenation

We'll reach out to this number within 24 hrs